News and Media

Product Launch Announcement: Palboheal 125 (Palbociclib 125mg) Capsule We are proud to introduce Palboheal 125, a premium formulation of Palbociclib 125mg capsules, developed to provide advanced targeted therapy in hormone receptor-positive breast cancer. Designed to support improved progression control, Palboheal 125 reflects our commitment to delivering innovative and reliable oncology solutions. 🔍 Product Overview Generic Name:…

Product Launch Announcement: Lenvaheal 4 (Lenvatinib 4mg) Capsule We are proud to introduce Lenvaheal 4 capsules is a targeted oral anticancer therapy containing Lenvatinib 4mg, designed to inhibit tumor growth and angiogenesis. It is widely used in the management of advanced and progressive cancers, offering a clinically proven option with precision-driven action. 🔍 Product Overview Generic…

Product Launch Announcement: Olanib 150 (Olaparib 150mg) Tablet We are proud to introduce  Olanib 150, a high-quality formulation of Olaparib 150mg tablets, designed to provide targeted therapy in the management of specific BRCA-mutated cancers. Olanib 150 represents our commitment to delivering advanced oncology solutions that align with global treatment standards. 🔍 Product Overview Generic Name: Olaparib…

Product Launch Announcement: Anastrol 1 – Anastrozole 1mg tablet We are proud to introduce Anastrol 1, containing Anastrozole 1mg, a trusted and clinically proven aromatase inhibitor designed for the effective management of hormone receptor-positive breast cancer in postmenopausal women. 🔍 Product Overview Generic Name: Anastrozole Strength: 1mg Formulation: Tablet Primary Indications: Anastrol 1 – Anastrozole 1mg…

Product Launch Announcement: Trustmox 500 (Amoxicillin 500mg) Capsule We are proud to introduce Trustmox 500 capsule is a broad-spectrum antibiotic containing Amoxicillin 500mg, widely trusted for the effective treatment of common bacterial infections. Known for its proven efficacy, safety profile, and high patient compliance, Trustmox 500 supports reliable infection control across multiple therapeutic areas. 🔍 Product…

Product Launch Announcement: Lenvaheal 10 (Lenvatinib 10mg) Capsule We are proud to introduce Lenvaheal 10 capsules is a targeted oral anticancer therapy containing Lenvatinib 10mg, designed to inhibit tumor growth and angiogenesis. It is widely used in the management of advanced and progressive cancers, offering a clinically proven option with precision-driven action. 🔍 Product Overview Generic…

Product Launch Announcement: Iverclear 20 (Ivermectin 20mg) Tablet We are proud to introduce Iverclear 20 is an oral antiparasitic medication containing Ivermectin 20mg, widely used for the treatment of various parasitic infections. It is known for its broad-spectrum activity, well-established safety profile, and effectiveness in both individual and mass treatment programs. 🔍 Product Overview Generic Name:…

Product Launch Announcement: Dasib 50 (Dasatinib 50mg) Tablet We are proud to introduce Dasib 50 is an oral targeted anti-cancer therapy containing Dasatinib 50mg, developed for the treatment of specific hematological malignancies. As a potent tyrosine kinase inhibitor, Dasib 50 offers effective disease control in patients with chronic myeloid leukemia and related conditions, supporting improved clinical…

Product Launch Announcement: Axilyta 5 (Axitinib 5mg) Tablet We are proud to introduce Axilyta 5 is a targeted oral anti-cancer therapy containing Axitinib 5mg, designed for the effective management of advanced renal cell carcinoma. As a potent and selective tyrosine kinase inhibitor, Axilyta 5 helps inhibit tumor angiogenesis, slowing disease progression and improving clinical outcomes. 🔍…

Product Launch Announcement: Abiramale 500 (Abiraterone Acetate 500mg) Tablet We are proud to introduce Abiramale 500 is an oral hormonal anti-cancer therapy containing Abiraterone Acetate 500mg, indicated for the management of advanced prostate cancer. By effectively suppressing androgen production, Abiramale 500 helps slow disease progression and supports improved survival outcomes in patients with metastatic disease. 🔍…